QQ客服 官方微博 反馈留言

浏览/检索结果: 共4条，第1-4条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择发表日期升序发表日期降序作者升序作者降序提交时间升序提交时间降序题名升序题名降序 Influence of miR-26b on hepatic cirrhosis and portal pressure in rats with cirrhotic porta hypertension by targeting hENT1 depending on RhoA/ROCK-1 pathway 期刊论文 EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 卷号: 23, 期号: 4 作者:  Chen, Y.;  Tian, Y. 收藏  |  浏览/下载：16/0  |  提交时间：2019/12/05 miR-26b  RhoA/ROCK-1  hENT1  Hepatic cirrhosis  Portal hypertension   Precision design of nanomedicines to restore gemcitabine chemosensitivity for personalized pancreatic ductal adenocarcinoma treatment 期刊论文 BIOMATERIALS, 2018, 卷号: 158, 页码: 44-55 作者:  Zhao, Xiao;  Wang, Xiuchao;  Sun, Wei;  Cheng, Keman;  Qin, Hao 收藏  |  浏览/下载：64/0  |  提交时间：2018/04/10 Nanocarriers  Gemcitabine  Pancreatic Ductal Adenocarcinoma  Hent1  Rrm2   Precision design of nanomedicines to restore gemcitabine chemosensitivity for personalized pancreatic ductal adenocarcinoma treatment 期刊论文 BIOMATERIALS, 2018, 卷号: 158 作者:  Zhao, Xiao;  Wang, Xiuchao;  Sun, Wei;  Cheng, Keman;  Qin, Hao 收藏  |  浏览/下载：15/0  |  提交时间：2019/12/05 Nanocarriers  Gemcitabine  Pancreatic ductal adenocarcinoma  hENT1  RRM2   Antitumor effect of gemcitabine-loaded albumin nanoparticle on gemcitabine-resistant pancreatic cancer induced by low hENT1 expression 期刊论文 INTERNATIONAL JOURNAL OF NANOMEDICINE, 2018, 卷号: 13 作者:  Guo, Zhongyi;  Wang, Feng;  Di, Yang;  Yao, Lie;  Yu, Xinzhe 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/05 pancreatic cancer  gemcitabine resistance  albumin nanoparticles  low hENT1 expression  PDX model